Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Eli Lilly is close to acquiring a cancer biotechnology company
According to sources familiar with the matter, Eli Lilly is in advanced negotiations to acquire Kelonia Therapeutics for over $2 billion. The sources said that if negotiations do not break down, the deal could be reached as early as Monday. They also stated that if Kelonia reaches certain milestones, the deal price could include additional consideration. (Sina Finance)